May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Results of Wavefront–guided surface ablation for myopia and astigmatism correction in primary eyes.
Author Affiliations & Notes
  • A. Laurenzi
    Refractive Surgery, Cleveland Clinic Foundation, Cole Eye Institute, Cleveland, OH
  • M.R. Chalita
    Refractive Surgery, Cleveland Clinic Foundation, Cole Eye Institute, Cleveland, OH
  • M.V. Netto
    Refractive Surgery, Cleveland Clinic Foundation, Cole Eye Institute, Cleveland, OH
  • M. Xu
    Refractive Surgery, Cleveland Clinic Foundation, Cole Eye Institute, Cleveland, OH
  • R. Krueger
    Refractive Surgery, Cleveland Clinic Foundation, Cole Eye Institute, Cleveland, OH
  • Footnotes
    Commercial Relationships  A. Laurenzi, None; M.R. Chalita, None; M.V. Netto, None; M. Xu, None; R. Krueger, Alcon R.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 2858. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Laurenzi, M.R. Chalita, M.V. Netto, M. Xu, R. Krueger; Results of Wavefront–guided surface ablation for myopia and astigmatism correction in primary eyes. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):2858.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Evaluate the outcome of wavefront–guided surface ablation outcomes for the correction of myopia and astigmatism. Methods: Twenty one eyes (20patients) of individuals that underwent wavefront–guided surface ablation (PRKor LASEK) were evaluated. Complete ophthalmologic exam, corneal topography and wavefront measurements were performed. Uncorrected visual acuity(UCVA), best corrected visual acuity (BCVA), manifest refaction and wavefront analysis were evaluated preoperatively, 1week, 3 months, and 6 months after surgery. Wavefront measurements were assessed using the LADARWave device. Statistical analysis was performed using paired T–test to assess whether there was significant change after the surgery, and results were considered significant at a P valueof <0.05. Results: One month after surgery, UCVA was >20/40 in 81.81% of eyes( > 20/20 in 31.81%) and BCVA was > 20/40 in 100% ( > 20/20 in 77.27%). Wavefront analysis revealed total aberrations reduction in 100%of eyes. Three months postoperatively, UCVA was > 20/40 in 100% of eye( 20/20 in 41.66%) and BCVA was > 20/40 in 100% ( > 20/20 in 100%). Higher order aberrations, coma, spherical aberration and other terms were significantly induced at 1 month postop. At the 3 month follow–up there was no statistically significant induction of higher order aberrations; with coma, spherical aberration and other term values very similar to preop. Conclusions: Wavefront–guided surface ablation represents a good option for laser vision correction. All eyes showed reduciton in pre–existing total aberrations. Some high order aberration components decreased in this initial series.

Keywords: none 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×